On January 21, 2016, Cure First brought together prominent experts from a variety of disciplinesclinical oncology, computational sciences, patient advocacy, pharmaceutical R&D, cancer research, and geneticsto share their work and vision about the realities and possibilities of new cancer therapies.


MED Talk Presentations

CARLA GRANDORI, MD, PhD: "A Blueprint for Future Drug Target Discovery."

BOB EISENMAN, PhD: "Oncogenesis: It Takes a Network."

RAVI PANDYA: "Computational Medicine for Cancer."

VK GADI, MD, PhD: "Breakthroughs in Fighting Breast Cancer."

JERRY RADICH, MD: "The Genetics of Luck."

ILYA SHMULEVICH, PhD: "The Engineering Approach to Cancer."


Cancer Think Tank was a great way to meet the diverse people in the cancer community— researchers, clinicians, patients, and advocates—to share ideas, to explore collaborations, and to be inspired towards our common goal. I’m looking forward to the next one.
— Ravi Pandya, Microsoft Research

Cancer Think Tank provided a forum for experts to consider the potential of applying the latest advances in functional genomics, cutting-edge robotic technology and high-throughput screening (HTS) to identify the possibilities of personalized medicine and to further our understanding of how to kill cancer.

Platforms and insights into potentially groundbreaking science and technology were shared through MED Talk presentations. Then, working with small groups, facilitators helped harness ideas and examples of what could be done to develop new approaches for treating cancer. Research themes that surfaced from group interactions were shared with the larger group for further investigation. The facilitators are currently working to identify topics for potential grants and will be contacting Cancer Think Tank participants to review these ideas and to solicit their collaboration in developing them into grants.

Cancer Think Tank volunteers with Dr Carla Grandori

Cancer Think Tank volunteers with Dr Carla Grandori

Funding for specific initiatives emerging from the conference will be pursued in the coming months. Participants interested in working with other specialists will be invited to write segments of grant applications using a structured approach to encourage faster development. Strategic submissions to funding institutions such as the NIH and NCI will follow.

NEXT STEPS

  • FEBRUARY: Consolidate ideas and create teams.
  •  MARCHMAY: Gather ideas, draft proposals and investigate possible funding sources.
  • JUNEFALL: Submit applications according to specific deadlines.
  •  Winter 2016/17: BEGIN RESEARCH

Collaboration across diverse specialties, especially in research, is the best way to encourage innovation and Cancer Think Tank did just that. It was fun, inspiring and I was glad to have been a part of it.
— Ilya Shmulevich, PhD, Computational Biologist, Professor, Institute for Systems Biology, Seattle, WA


MED TalkS

BOB EISENMAM: "Oncogenesis: It Takes a Network"—What does it take to find the personalized cure for cancer?

ILYA SHMULEVICH: "The Engineering Approach to Cancer"—How can analytical tools traditionally used in engineering, such as systems modeling and simulation, be applied to the problems of developing personalized therapies for cancer?

JERRY RADICH: "The Genetics of Luck"—Some patients who should do great, don’t. Others shouldn’t do well, but do great. This is often ascribed to luck. Is it, or is there something more?

RAVI PANDYA: "Computational Medicine for Cancer"—Sophisticated software algorithms and large scale cloud computing systems are becoming essential to understanding and treating the complex and diverse genomic alterations that cause cancer.

VK GADI: "Breakthroughs in Fighting Breast Cancer"—Building functional genomics maps to deliver better treatments.


Cancer Think Tank sponsors: